Michael Gdalevich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Gdalevich has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Baruch Lev
Stern School of Business, New York University, New York, USA
1 shared publication C. Block
Hadasseh Hospital
1 shared publication- Daniel Mimouni
Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
1 shared publication - Ehud Kaliner
Division of Epidemiology, Ministry of Health, 39 Yirmiyahu Street, Jerusalem 9101002, Israel
1 shared publication - Francis B. Mimouni
Tel Aviv Univeristy, Gray Faculty of Medicine Department of Pediatrics, Leumit Health Services and Leumit Research Institute Klatzkin St 35 , Tel Aviv-Yafo, 6997801
1 shared publication - Haim Bar
Department of Statistics, University of Connecticut, Storrs, USA
1 shared publication
Latest Publications
- 30 July 2025
- Published by SAGE Publications in International Journal of Risk & Safety in Medicine
- Vol. 36 (4) , 313
Population-level COVID-19 mortality trends
- 30 July 2025
- Published by SAGE Publications in International Journal of Risk & Safety in Medicine
- Vol. 36 (4) , 313
Population-level COVID-19 mortality trends
- 1 December 2016
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 22, S140-S145
Public health response to the silent reintroduction of wild poliovirus to Israel, 2013–2014
- 1 December 2016
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 22, S140-S145
Public health response to the silent reintroduction of wild poliovirus to Israel, 2013–2014
- 10 September 2008
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 22 (10) , 1232-1235
Pemphigus – analysis of epidemiological factors in 155 patients
Background Pemphigus vulgaris is a chronic autoimmune mucocutaneous blistering disease. Only a few studies have evaluated the epidemiological and aetiological parameters of pemphigus vulgaris in a large group of patients over the long term.Methods The sample included 155 patients with a diagnosis of pemphigus who attended the pemphigus clinic of a major tertiary medical centre from 1976 to 2004. Data were obtained from the patient files and entered into an ad hoc form; patients were contacted by telephone for missing information.Results The female‐to‐male ratio was 1.5 : 1. Non‐Ashkenazi Jews accounted for 37% of the sample. In only 10% of the patients was a potential aetiologic or precipitating factor identified.Conclusions Pemphigus vulgaris is characterized by a female predominance, consistent with other autoimmune disease. The gender, age and ethnic distribution of affected patients have not changed in the last 40 years. In the vast majority of cases, the aetiologic or precipitating factor is unknown, although drugs appear to be very rare.
- 10 September 2008
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 22 (10) , 1232-1235
Pemphigus – analysis of epidemiological factors in 155 patients
Background Pemphigus vulgaris is a chronic autoimmune mucocutaneous blistering disease. Only a few studies have evaluated the epidemiological and aetiological parameters of pemphigus vulgaris in a large group of patients over the long term.Methods The sample included 155 patients with a diagnosis of pemphigus who attended the pemphigus clinic of a major tertiary medical centre from 1976 to 2004. Data were obtained from the patient files and entered into an ad hoc form; patients were contacted by telephone for missing information.Results The female‐to‐male ratio was 1.5 : 1. Non‐Ashkenazi Jews accounted for 37% of the sample. In only 10% of the patients was a potential aetiologic or precipitating factor identified.Conclusions Pemphigus vulgaris is characterized by a female predominance, consistent with other autoimmune disease. The gender, age and ethnic distribution of affected patients have not changed in the last 40 years. In the vast majority of cases, the aetiologic or precipitating factor is unknown, although drugs appear to be very rare.
- 1 August 1998
- Published by Wiley in International Journal of Dermatology
- Vol. 37 (8) , 586-587
The epidemiologic trends of scabies among Israeli soldiers: a 28‐year follow‐up
Background Scabies is not a notifiable disease in most countries. Thus, the reported rates of the disease in large populations are usually inaccurate and based on estimations. Scabies is usually reported only when large outbreaks occur. Objective This article describes the global epidemiology of scabies in the Israel Defense Force. The data used in this study are based on the routine and mandatory reporting of every individual case of scabies to the Army Health Branch Epidemiology Department since 1968. Results There was a period of 13 years of quiescence from the implementation of reporting in 1968 until 1981. This period was followed by an epidemic of 15 years, peaking in 1985 and 1986, and returning to the baseline rates of the quiescent period by 1996. This prospectively observed pattern of at least 13 years of quiescence followed by a peak of 15 years is consistent with other, mostly retrospective, reports. Although the peak may have been triggered by the “Lebanon” war of 1982, it is noticeable that no peak was observed during the “Yom Kippur” war (1973). Conclusions Prospective, mandatory reporting of the kind described here should help to better understand the epidemiology of scabies.
- 1 August 1998
- Published by Wiley in International Journal of Dermatology
- Vol. 37 (8) , 586-587
The epidemiologic trends of scabies among Israeli soldiers: a 28‐year follow‐up
Background Scabies is not a notifiable disease in most countries. Thus, the reported rates of the disease in large populations are usually inaccurate and based on estimations. Scabies is usually reported only when large outbreaks occur. Objective This article describes the global epidemiology of scabies in the Israel Defense Force. The data used in this study are based on the routine and mandatory reporting of every individual case of scabies to the Army Health Branch Epidemiology Department since 1968. Results There was a period of 13 years of quiescence from the implementation of reporting in 1968 until 1981. This period was followed by an epidemic of 15 years, peaking in 1985 and 1986, and returning to the baseline rates of the quiescent period by 1996. This prospectively observed pattern of at least 13 years of quiescence followed by a peak of 15 years is consistent with other, mostly retrospective, reports. Although the peak may have been triggered by the “Lebanon” war of 1982, it is noticeable that no peak was observed during the “Yom Kippur” war (1973). Conclusions Prospective, mandatory reporting of the kind described here should help to better understand the epidemiology of scabies.
- 1 March 1994
- Published by Springer Nature in Infection
- Vol. 22 (2) , 69-71
First recorded outbreaks of meningococcal disease in the Israel Defence Force: Three clusters due to serogroup C and the emergence of resistance to rifampicin
Outbreaks of meningococcal disease were observed for the first time in the Israel Defence Force (I. D. F.) in 1992 and 1993, while in previous years, cases appeared in sporadic fashion. Two episodes in the winter of 1992 involving three and two individuals, respectively, were caused byNeisseria meningitidis group C, which was notypable and nonsubtypable (C:NT:-). Three cases in one event in early 1993 were due to group C:NT:P1.2, the two secondary cases being caused by strains completely resistant to rifampicin. While these outbreaks were small, they should be seen against a background of the emergence of relatively virulent clones of serogroup C which have caused significant outbreaks in several countries. This and the drug resistance problem will require medical decision-makers to review strategies for the prevention of meningococcal disease, taking into account alternative agents for chemoprophylaxis as well as a possible role for vaccination. In den Jahren 1992 und 1993 wurden erstmals im israelischen Militär Ausbrüche von Meningokokkenerkrankungen beobachtet, vorher waren nur sporadische Fälle aufgetreten. Bei zwei Episoden im Winter 1992 waren drei beziehungsweise zwei Personen betroffen. Der Erreger warNeisseria meningitidis Gruppe C; die Isolate waren nicht typisierbar oder subtypisierbar (C : NT :-). Drei Fälle, die Anfang 1993 auftraten, wurden durch Gruppe C : NT : P1.2 verursacht; die beiden sekundären Fälle wurden durch Stämme ausgelöst, die gegen Rifampicin vollständig resistent waren. Wenn diese Ausbrüche auch klein waren, sollte bedacht werden, daß in verschiedenen Ländern relativ virulente Stämme von Serogruppe C auftraten, die umfangreiche Epidemien ausgelöst haben. Aus diesem Grund und wegen des Problems der Antibiotikaresistenz sollten Fachgremien die Strategien für die Prävention der Meningokokkeninfektion neu überdenken und alternative Substanzen für die Chemoprophylaxe einbeziehen sowie die Bedeutung der Impfung berücksichtigen.
- 1 March 1994
- Published by Springer Nature in Infection
- Vol. 22 (2) , 69-71
First recorded outbreaks of meningococcal disease in the Israel Defence Force: Three clusters due to serogroup C and the emergence of resistance to rifampicin
Outbreaks of meningococcal disease were observed for the first time in the Israel Defence Force (I. D. F.) in 1992 and 1993, while in previous years, cases appeared in sporadic fashion. Two episodes in the winter of 1992 involving three and two individuals, respectively, were caused byNeisseria meningitidis group C, which was notypable and nonsubtypable (C:NT:-). Three cases in one event in early 1993 were due to group C:NT:P1.2, the two secondary cases being caused by strains completely resistant to rifampicin. While these outbreaks were small, they should be seen against a background of the emergence of relatively virulent clones of serogroup C which have caused significant outbreaks in several countries. This and the drug resistance problem will require medical decision-makers to review strategies for the prevention of meningococcal disease, taking into account alternative agents for chemoprophylaxis as well as a possible role for vaccination. In den Jahren 1992 und 1993 wurden erstmals im israelischen Militär Ausbrüche von Meningokokkenerkrankungen beobachtet, vorher waren nur sporadische Fälle aufgetreten. Bei zwei Episoden im Winter 1992 waren drei beziehungsweise zwei Personen betroffen. Der Erreger warNeisseria meningitidis Gruppe C; die Isolate waren nicht typisierbar oder subtypisierbar (C : NT :-). Drei Fälle, die Anfang 1993 auftraten, wurden durch Gruppe C : NT : P1.2 verursacht; die beiden sekundären Fälle wurden durch Stämme ausgelöst, die gegen Rifampicin vollständig resistent waren. Wenn diese Ausbrüche auch klein waren, sollte bedacht werden, daß in verschiedenen Ländern relativ virulente Stämme von Serogruppe C auftraten, die umfangreiche Epidemien ausgelöst haben. Aus diesem Grund und wegen des Problems der Antibiotikaresistenz sollten Fachgremien die Strategien für die Prävention der Meningokokkeninfektion neu überdenken und alternative Substanzen für die Chemoprophylaxe einbeziehen sowie die Bedeutung der Impfung berücksichtigen.